This content is machine translated COVID-19 SARS-CoV-2 and the coagulopathy: a Swiss perspective. Within the framework of this year’s Swiss Oncology and Hematology Congress (SOHC), which took place completely virtually for the first time from November 18 to 21, PD Dr. med. Bernhard…
View Post 3 min This content is machine translated Myeloid diseases New trends in the treatment of acute myeloid leukemia Understanding about myeloid diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), is becoming more concrete thanks to intensive research. Recent study results have shown that there is…
View Post 3 min This content is machine translated Sponsored Content Support rational use of blood products in times of COVID-19 – with Patient Blood Management (PBM) PBM is an evidence-based approach that aims to improve clinical outcomes and ensure the safety of the blood supply, while saving money. It is based on the following 3 pillars1,2
View Post 2 min This content is machine translated Schwartz-Bartter syndrome Effectively balancing electrolyte imbalances: focus on osmoregulation Nausea, vomiting, headaches and muscle cramps may also result from water retention. In Schwarzt-Bartter syndrome, this is triggered by ADH accumulation. The cause is usually small cell lung cancer, but…
View Post 3 min This content is machine translated Cancer medicine of the future Car-T cell therapy and its application in practice CAR-T cell technology is considered the latest achievement in cancer medicine. The first approvals in Europe took place in mid-2018 – Switzerland followed at the end of 2018. Currently, the…
View Post 2 min This content is machine translated Multiple Myeloma Challenge accepted: Breaking boundaries in therapy Multiple myeloma is rare, but is one of the most common tumors of bone and bone marrow. Annually, there are about six to eight new cases per 100,000 inhabitants. Almost…
View Post 11 min This content is machine translated Sideropenia Iron deficiency in the oncological patient Worldwide, iron deficiency is the most common deficiency disease. In Europe, the prevalence is 5-10% and is one of the most common causes of anemia, accounting for about 50%. An…
View Post 2 min This content is machine translated Hematology Challenges and opportunities of precision therapy In recent years, the ever-improving molecular understanding of malignant diseases has opened up avenues for targeted treatment strategies. Tumor genomic analyses are becoming increasingly important in providing patients with access…
View Post 2 min This content is machine translated Multiple Myeloma Focus on symptom control – treatment options at a glance One of the most important decisions that must be made at the onset of symptomatic myeloma is that of adequate therapy. While not yet curable, a number of good options…
View Post 5 min This content is machine translated Comorbid iron deficiency in heart failure Evidence-based beneficial effects of intravenous iron supplementation. Iron deficiency is common in heart failure patients. In addition to a reduction in exercise capacity and quality of life, an increased risk of mortality is associated with it –…
View Post 3 min This content is machine translated Pediatric Oncology No cancer like any other: when life stops Cancer in childhood and adolescence places special demands on both those affected and the physicians treating them. Specialized, interdisciplinary centers therefore work closely in defined infrastructures to ensure the survival…
